BR112012001151A2 - complexo de substância ativa e formulação compreendendo o complexo de substância ativa - Google Patents

complexo de substância ativa e formulação compreendendo o complexo de substância ativa

Info

Publication number
BR112012001151A2
BR112012001151A2 BR112012001151A BR112012001151A BR112012001151A2 BR 112012001151 A2 BR112012001151 A2 BR 112012001151A2 BR 112012001151 A BR112012001151 A BR 112012001151A BR 112012001151 A BR112012001151 A BR 112012001151A BR 112012001151 A2 BR112012001151 A2 BR 112012001151A2
Authority
BR
Brazil
Prior art keywords
active substance
substance complex
formulation
complex
active
Prior art date
Application number
BR112012001151A
Other languages
English (en)
Other versions
BR112012001151B1 (pt
Inventor
Sabrina John
Original Assignee
Richter Chem Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Chem Lab filed Critical Richter Chem Lab
Publication of BR112012001151A2 publication Critical patent/BR112012001151A2/pt
Publication of BR112012001151B1 publication Critical patent/BR112012001151B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112012001151A 2010-04-12 2010-06-29 composição para aplicação tópica BR112012001151B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102010014666 2010-04-12
PCT/EP2010/059238 WO2011127994A1 (de) 2010-04-12 2010-06-29 Wirkstoffkomplex und formulierung umfassend denselben

Publications (2)

Publication Number Publication Date
BR112012001151A2 true BR112012001151A2 (pt) 2016-11-22
BR112012001151B1 BR112012001151B1 (pt) 2020-02-04

Family

ID=43216287

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012001151A BR112012001151B1 (pt) 2010-04-12 2010-06-29 composição para aplicação tópica

Country Status (5)

Country Link
US (1) US9549957B2 (pt)
AU (1) AU2010350888B2 (pt)
BR (1) BR112012001151B1 (pt)
CA (1) CA2769678C (pt)
WO (1) WO2011127994A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102526331B (zh) * 2012-01-13 2013-06-19 刘姣长 一种临床护理用治疗尿布皮炎的中药擦洗剂
EP3226832B1 (en) 2014-12-03 2022-05-25 Mary Kay, Inc. Exfoliating cosmetic compositions
GB2542873A (en) * 2015-04-16 2017-04-05 Elc Man Llc Unit dose packages, compositions, and treatment regimens to deliver pro-resolution pathway stimulators to keratin surfaces
KR102295786B1 (ko) * 2016-09-06 2021-09-01 신파 티엔리 파머슈티컬 컴퍼니 리미티드 (항저우) 스킨케어 및/또는 상처치유 촉진에 있어서 복령 추출물 및 이의 활성 성분의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY124001A (en) * 1999-04-23 2006-06-30 E Excel Int Dietary supplements containing dehydrated cactus fruit juice and ginseng berry juice
DE10151649A1 (de) * 2001-10-11 2003-05-08 Peter Elsner Verwendung von Lanostanen als Inhibitoren von 3alpha-Hydroxysteroid-Dehydrogenase und Cyclooxygenasen
KR100742378B1 (ko) * 2005-05-17 2007-07-24 김정진 생약재를 함유하는 아토피성 피부염 치료용 조성물
CN1899543B (zh) * 2006-07-10 2010-05-12 左耀武 一种治疗小儿发热的外贴膏及其制备方法
KR100907685B1 (ko) * 2007-06-01 2009-07-14 게놈앤메디신(주) 노근으로부터 분리한 페놀성 화합물을 유효성분으로함유하는 피부 미백용 화장료 조성물
CN101264253A (zh) * 2008-05-08 2008-09-17 北京天科仁祥医药科技有限公司 一种治疗尿崩症的中药组合物及其制备方法

Also Published As

Publication number Publication date
WO2011127994A1 (de) 2011-10-20
US20120189651A1 (en) 2012-07-26
CA2769678A1 (en) 2011-10-20
CA2769678C (en) 2019-06-04
AU2010350888A1 (en) 2012-02-02
BR112012001151B1 (pt) 2020-02-04
US9549957B2 (en) 2017-01-24
AU2010350888B2 (en) 2015-10-29

Similar Documents

Publication Publication Date Title
BR112013013402A2 (pt) combinações de ingredientes ativos que compreendem piridiletilbenzamidas e outros ingredientes ativos
CR20150380A (es) Compuestos de carbamoilpiridona policíclicos y su uso farmacéutico
BR112012013148A2 (pt) formulação farmacêutica e uso
BR112013002845A2 (pt) combinação de susbtâncias ativas
ZA201300464B (en) Active substance combinations with insecticide and acaricide properties
BR112013013311A2 (pt) agente terapêutico de indução de citotoxicidade
BR112013010185A2 (pt) composições pesticidas e processos relacionados às mesmas
DK3175711T3 (da) Parasitiske sammensætninger indeholdende multiple aktivstoffer, fremgangsmåder og anvendelser deraf
IT1398930B1 (it) Formulazioni farmaceutiche bistrato contenenti agonisti ed antagonisti oppioidi.
PL2643010T3 (pl) Biologicznie aktywny kompleks i jego otrzymywanie
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
IT1403847B1 (it) Composizioni farmaceutiche comprendenti rifaximina e loro uso.
BR112015011111A2 (pt) proteína multifuncional e formulação farmacêutica
FR2975004B1 (fr) Nouvel actif anti-rougeurs et compositions cosmetiques le comprenant
BR112012028157A2 (pt) dispositivo para colheita de azeitonas e similares
DK3650125T3 (da) Væskeforstøver og fremgangsmåder
CO6781486A2 (es) Compuestos y su uso
FR2958157B1 (fr) Composition cosmetique et pharmaceutique comprenant du n-acetyl-glucosamine-6-phosphate
BR112013007617A2 (pt) artigo absorvente com loção
BR112013016223A2 (pt) películas e composições compreendendo as mesmas
BRPI1008887A2 (pt) peptídeos de foxm1 e vacinas contendo os mesmo
PL2521445T3 (pl) Preparat i jego zastosowanie
BR112013010709A2 (pt) derivado de ácido trans-2-decenoico e agente farmacêutico contendo o mesmo
BR112013017267A2 (pt) formulação de lipossomas, suspensão e composição farmacêutica
FR2964937B1 (fr) Triporteur et direction de triporteur

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/06/2010, OBSERVADAS AS CONDICOES LEGAIS.